Life Science sector operates under different pressures (regulations & Audits) and Market influences compared to other industries. While the industry as a whole is often targeted as slow to adapt to change, 2018 saw a concerted focus to address past mistakes and adapt to the modern healthcare landscape.
Some of the life sciences industry trends, such as efforts to disrupt pricing models, have yet to gain signiﬁcant traction but precedents have been set indicating the rise of value-based models. Meanwhile, organizations are investing heavily into therapeutic innovations in gene therapy, cell therapy, diagnostics, and biomarker testing. Life sciences organizations also continue to explore the utility of AI, machine learning, and Blockchain Technology to augment standard models and processes.